Omega Healthcare (OHI) Q1 2026 earnings review
Consistent Execution Drives Accretion Amid Portfolio Pruning
Omega Healthcare delivered a textbook quarter of stable, accelerating growth. AFFO per share rose 9.3% YoY to $0.82, driven by $251M in new Q1 investments and robust operator performance. Management successfully pruned the portfolio by securing a $480M exit for 18 struggling CommuniCare facilities. By shedding assets with sub-1.0x coverage and redeploying capital at ~10% yields, Omega is manufacturing its own organic growth. This reliable execution led management to raise the lower end of its 2026 AFFO guidance, pushing the midpoint to $3.22.
🐂 Bull Case
The $480M sale of 18 CommuniCare facilities removes a major headache (0.87x coverage). Redeploying these proceeds into Omega's current ~10% yield pipeline will drive an estimated $0.03 per share in FAD accretion.
Core portfolio EBITDAR coverage expanded to 1.58x, up from 1.51x a year ago. Operator fundamentals are solidifying, reducing the risk of sudden rent defaults.
🐻 Bear Case
Genesis remains in bankruptcy. While they paid $13.3M in Q1 rent and Omega provided a $26.7M DIP facility, the timeline for exit remains murky. A negative court ruling could still impair run-rate revenue.
Omega is shifting more capital into operationally intensive RIDEA structures and OpCo joint ventures. This introduces direct margin and labor exposure previously insulated by triple-net leases.
⚖️ Verdict: 🟢
Bullish. Omega's ability to consistently source 10% cash yields while pruning its weakest links is driving predictable, accelerating per-share growth. The CommuniCare disposition removes a major tail risk.
Key Themes
Core Operator Coverage is Accelerating
Operator health is the bedrock of a healthcare REIT. Trailing 12-month EBITDAR coverage reached 1.58x in Q4 2025 (reported in Q1 2026), continuing a flawless upward trajectory from 1.51x a year ago. Higher coverage means safer dividends and fewer restructuring headaches.
Strategic Disposition of CommuniCare Assets
Omega is selling 18 CommuniCare facilities for $480M. This is a massive win. These assets had a weak trailing EBITDAR coverage of 0.87x. By selling high-risk assets and planning to redeploy the capital, management eliminates a potential default bomb and expects to add $0.03 to FAD in the process.
Investment Innovation: Saber OpCo & RIDEA Expansion
Omega is evolving past purely passive real estate. In Q1, the company acquired a 9.9% equity interest in Saber OpCo for $93M (minimum 8% annualized yield) and placed a new Alabama senior housing facility into a RIDEA structure. This allows Omega to capture operational upside rather than just collecting fixed rent checks.
Pockets of Deep Distress Remain
While overall portfolio coverage is a healthy 1.58x, the CommuniCare disposition proves the averages mask severe individual weakness. An 0.87x coverage ratio means the operator was losing money before paying rent. Investors must monitor whether other regional operators are similarly distressed beneath the blended portfolio metrics.
Genesis Bankruptcy Continues
Genesis Healthcare has been in Chapter 11 since July 2025. While Genesis continues to pay rent ($13.3M in Q1) and Omega funded $25M of a new $26.7M DIP facility, the prolonged restructuring ties up management resources and carries inherent legal risks until a successful emergence or asset sale is completed.
Cost of Capital Advantage in a High-Rate Macro Environment
Despite elevated interest rates pressuring the broader real estate sector, Omega's stock strength allows accretive equity funding. In Q1, Omega issued 2.2M shares via ATM and DRIP for $107M at an average price near $48. This highly competitive cost of capital funds ~10% yielding acquisitions, driving the bottom line.
Other KPIs
Omega deployed $126M into real estate (including 13 Georgia SNFs at a 10.6% initial cash yield), $97M into unconsolidated entities (primarily the Saber OpCo stake), and $27M into loans. The company added another $75M in acquisitions early in Q2.
Accelerating. Up 17% YoY in absolute dollars and 9.8% on a per-share basis ($0.78 vs $0.71). FAD easily covers the $0.67 quarterly dividend, resulting in a safe ~86% payout ratio.
Guidance
Accelerating. Management raised the low end of the range, shifting the midpoint to $3.22. This implies healthy YoY growth over FY25 and reflects the accretive impact of Q1 acquisitions and the pending CommuniCare sale redeployment.
Key Questions
CommuniCare Capital Redeployment
With the $480M from the CommuniCare sale coming in Q2, how quickly can this capital be redeployed, and will it be weighted more toward traditional SNF triple-net leases or new RIDEA structures?
Genesis Exit Strategy
Genesis has been in bankruptcy for nearly a year. What is the latest timeline for their emergence, and what is the expected recovery on the $25M DIP financing and existing term loans?
Saber OpCo Performance
With the 9.9% Saber OpCo investment carrying an 8% minimum yield, how is the underlying operational cash flow performing against initial underwriting, and when do you expect yield upside?
Maplewood Rent Trajectory
Maplewood paid $19.4M in Q1 and is guided to pay $19.5M per quarter in 2026. What needs to happen operationally for Maplewood to return to its original contractual rent schedule?